Ian Bilmon
Impact in
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Transplantation top 10%
Papers in
- Hematology 14
- Hematopoietic Stem Cell Transplantation 10
- Acute Myeloid Leukemia Research 9
- Chronic Myeloid Leukemia Treatments 2
- Oncology 8
- CAR-T cell therapy research 2
- Co-authors
- David J. Gottlieb (8 shared papers)Kenneth P. Micklethwaite (6 shared papers)Emily Blyth (6 shared papers)Leighton Edward Clancy (2 shared papers)John Kwan (5 shared papers)Kenneth Francis Bradstock (2 shared papers)Ming‐Celine Dubosq (1 shared paper)David C. Bishop (1 shared paper)
- Journals
- Blood (5 papers)Transplantation and Cellular Therapy (4 papers)Cytotherapy (2 papers)Journal of Clinical Oncology (2 papers)British Journal of Haematology (2 papers)
- Partner nations
- AustraliaNew ZealandUnited States
In The Last Decade
Ian Bilmon
25 papers receiving 501 citations
Ian Bilmon's Hit Papers
Peers
Comparison fields: 5 of 54
- Hematology 301
- Transplantation 24
- Oncology 174
- Genetics 42
- Immunology 73
Countries citing papers authored by Ian Bilmon
This map shows the geographic impact of Ian Bilmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Bilmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Bilmon more than expected).
Fields of papers citing papers by Ian Bilmon
This network shows the impact of papers produced by Ian Bilmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Bilmon. The network helps show where Ian Bilmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Bilmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Gilteritinib as Post-Transplant Maintenance for AML With Internal Tandem Duplication Mutation of FLT3 Hit paper breakdown → | 2024 | 117 |
| 2 | 2015 | 82 | |
| 3 | 2015 | 53 | |
| 4 | 2015 | 37 | |
| 5 | 2014 | 34 | |
| 6 | 2012 | 24 | |
| 7 | 2023 | 22 | |
| 8 | 2016 | 19 | |
| 9 | 2020 | 15 | |
| 10 | 2012 | 15 | |
| 11 | 2018 | 15 | |
| 12 | 2017 | 14 | |
| 13 | 2020 | 12 | |
| 14 | 2018 | 8 | |
| 15 | 2024 | 8 | |
| 16 | 2022 | 7 | |
| 17 | 2023 | 6 | |
| 18 | 2018 | 6 | |
| 19 | 2020 | 3 | |
| 20 | 2019 | 3 |
About Ian Bilmon
Ian Bilmon is a scholar working on Hematology, Oncology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 25 papers that have together received 507 indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (10 papers), Acute Myeloid Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), CAR-T cell therapy research (2 papers), T-cell and B-cell Immunology (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Childhood Cancer Survivors' Quality of Life (2 papers). The work is most often cited by research in Hematology (301 citations), Transplantation (24 citations), Oncology (174 citations), Genetics (42 citations) and Immunology (73 citations). Ian Bilmon has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include David J. Gottlieb, Kenneth P. Micklethwaite, Emily Blyth, Leighton Edward Clancy, John Kwan, Kenneth Francis Bradstock, Ming‐Celine Dubosq, David C. Bishop, Val Gebski and Gillian Huang. Their work appears in journals such as Blood, Transplantation and Cellular Therapy, Cytotherapy, Journal of Clinical Oncology and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.